Miloslavsky EM, et al. - Herein, the authors evaluated whether remission of ANCA-associated vasculitis (AAV) in the patients could be induced by an 8-week glucocorticoid course in combination with rituximab (RTX). They noted a similar rate of complete remission at six months due to an 8-week course of prednisone with RTX just as with the rituximab in AAV (RAVE) trial. This 8-week course demonstrated less adverse events but more frequent relapses.